Evidence map›Paper›PMID 39542700›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2025

Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study.

Lyduine E Collij, Gérard N Bischof, Daniele Altomare, Ilse Bader, Mark Battle, David Vállez García, Isadora Lopes Alves, Robin Wolz, Rossella Gismondi, Andrew Stephens and 13 more

Abstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. The clinical Alzheimer's disease spectrum classified in the A/T/N framework withEuropean journal of nuclear medicine and molecular imaging · 2026
    Observational
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. AI-enhanced Centiloid quantification of amyloid PET images.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Italian intersocietal recommendations for restructuring the diagnostic-therapeutic pathway for the implementation and appropriate use of anti-amyloid monoclonal antibodies in Alzheimer's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  16. Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [European journal of nuclear medicine and molecular imaging · 2025
    Article
  17. Calibration of multisite raters for prospective visual reads of amyloid PET scans.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Lyduine E CollijDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands; l.collij@amsterdamumc.nl.
Gérard N BischofDepartment of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Daniele AltomareDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Ilse BaderDepartment of Neurology, Alzheimercenter, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.
Mark BattleGE HealthCare, Amersham, United Kingdom.
David Vállez GarcíaDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.
Isadora Lopes AlvesBrain Research Center, Amsterdam, The Netherlands.
Robin WolzIXICO Plc, London, United Kingdom.
Rossella GismondiLife Molecular Imaging GmbH, Berlin, Germany.
Andrew StephensLife Molecular Imaging GmbH, Berlin, Germany.
Zuzana WalkerDivision of Psychiatry, Faculty of Brain Sciences, University College London, London, United Kingdom.
Philip ScheltensLSP Life Sciences, Amsterdam, The Netherlands.
Agneta NordbergDivision of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.
Juan Domingo GispertBarcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain.
Alexander DrzezgaDepartment of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Andrés PerissinottiBiomedical Research Networking Center of Bioengineering, Biomaterials, and Nanomedicine, Carlos III Health Institute, Madrid, Spain.
Silvia MorbelliDepartment of Medical Sciences, University of Turin, Turin, Italy.
Christopher BuckleyGE HealthCare, Amersham, United Kingdom.
Valentina GaribottoDivision of Nuclear Medicine and Molecular Imaging, Geneva University Hospitals, Geneva, Switzerland.
Giovanni B FrisoniLaboratory of Neuroimaging of Aging, University of Geneva, Geneva, Switzerland.
Gill FarrarGE HealthCare, Amersham, United Kingdom.
Frederik Barkhof
AMYPAD Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies have demonstrated strong agreement between routine clinical visual assessment and quantification, suggesting that quantification approaches could support assessment by less experienced readers or in challenging cases. However, all studies to date have implemented a retrospective case collection, and challenging cases were generally underrepresented.

Indexed as

AmyloidPositron-Emission TomographyAgedAlzheimer DiseaseFemaleHumansImage Processing, Computer-AssistedMaleMiddle AgedRetrospective StudiesAmyloidAlzheimeramyloid PETCentiloid quantificationmolecular imagingneurologyvisual read

Identifiers

PMID39542700
PMCPMC11705786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.